FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Eric Edgell

Research Profile

Chemicals & Drugs

Disorders

Concepts & Ideas

Geographic Areas

Europe

Procedures

Activities & Behaviors

Living Beings

Outpatients

Co-author Network

Publications

TOP 3
Lizheng Shi; Rodrigo Juarez; Jodi Hackworth; Eric T Edgell; Josep Maria Haro; Eduard Vieta; Mauricio Tohen
Open-label olanzapine treatment in bipolar I disorder: clinical and work functional outcomes.
Diego Novick; Manuel Bousono; David Suarez; José Manuel Olivares; Angel Luis Montejo; Josep Maria Haro; Eric T Edgell; Mark Ratcliffe
Use of concomitant medication with antipsychotic treatment in outpatients with schizophrenia: results from the European Schizophrenia Outpatients Health Outcomes (SOHO) study.
Isabelle Gasquet; Josep Maria Haro; Diego Novick; Eric T Edgell; Liam Kennedy; Jean Pierre Lepine
Pharmacological treatment and other predictors of treatment outcomes in previously untreated patients with schizophrenia: results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Eric Edgell (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2006: Lizheng Shi; Rodrigo Juarez; Jodi Hackworth; Eric T Edgell; Josep Maria Haro; Eduard Vieta; Mauricio Tohen
Open-label olanzapine treatment in bipolar I disorder: clinical and work functional outcomes.
Current medical research and opinion 2006;22(5):961-6.
2005: Diego Novick; Manuel Bousono; David Suarez; José Manuel Olivares; Angel Luis Montejo; Josep Maria Haro; Eric T Edgell; Mark Ratcliffe
Use of concomitant medication with antipsychotic treatment in outpatients with schizophrenia: results from the European Schizophrenia Outpatients Health Outcomes (SOHO) study.
Progress in neuro-psychopharmacology & biological psychiatry 2005;29(6):972-82.
2005: Isabelle Gasquet; Josep Maria Haro; Diego Novick; Eric T Edgell; Liam Kennedy; Jean Pierre Lepine
Pharmacological treatment and other predictors of treatment outcomes in previously untreated patients with schizophrenia: results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study.
International clinical psychopharmacology 2005;20(4):199-205.
2005: Martin Lambert; Josep Maria Haro; Diego Novick; Eric T Edgell; Liam Kennedy; Mark Ratcliffe; Dieter Naber
Olanzapine vs. other antipsychotics in actual out-patient settings: six months tolerability results from the European Schizophrenia Out-patient Health Outcomes study.
Acta psychiatrica Scandinavica 2005;111(3):232-43.
2005: Josep Maria Haro; Eric T Edgell; Diego Novick; J Alonso; Liam Kennedy; Peter B Jones; Mark Ratcliffe; Alan Breier
Effectiveness of antipsychotic treatment for schizophrenia: 6-month results of the Pan-European Schizophrenia Outpatient Health Outcomes (SOHO) study.
Acta psychiatrica Scandinavica 2005;111(3):220-31.
2003: M de Zélicourt; Roland Dardennes; Hélène Verdoux; Gian Gandhi; M-L Papatheodorou; Eric T Edgell; Babak Khoshnood; E Chomette; Christian Even; Francis Fagnani
[Bipolar I disorder in France: prevalence of manic episodes and hospitalisation-related costs].
L'Encéphale 2003;29(3 Pt 1):248-53.
2003: Josep Maria Haro; Eric T Edgell; Peter B Jones; J Alonso; S Gavart; KJ Gregor; P Wright; Martin Knapp
The European Schizophrenia Outpatient Health Outcomes (SOHO) study: rationale, methods and recruitment.
Acta psychiatrica Scandinavica 2003;107(3):222-32.
2003: Marie de Zelicourt; Roland Dardennes; Hélène Verdoux; Gian Gandhi; Babak Khoshnood; Eric Chomette; Marie-Laure Papatheodorou; Eric T Edgell; Christian Even; Francis Fagnani
Frequency of hospitalisations and inpatient care costs of manic episodes: in patients with bipolar I disorder in France.
PharmacoEconomics 2003;21(15):1081-90.
2003: Leah Kleinman; Ana Lowin; Emuella Flood; Gian Gandhi; Eric T Edgell; Dennis Revicki
Costs of bipolar disorder.
PharmacoEconomics 2003;21(9):601-22.
2003: Hege Urdahl; Martin Knapp; Eric T Edgell; G Ghandi; Josep Maria Haro
Unit costs in international economic evaluations: resource costing of the Schizophrenia Outpatient Health Outcomes Study.
Acta psychiatrica Scandinavica. Supplementum 2003;(416):41-7.
2003: L Prieto; Diego Novick; José Antonio Sacristán; Eric T Edgell; J Alonso
A Rasch model analysis to test the cross-cultural validity of the EuroQoL-5D in the Schizophrenia Outpatient Health Outcomes Study.
Acta psychiatrica Scandinavica. Supplementum 2003;(416):24-9.
2003: Josep Maria Haro; Eric T Edgell; P Frewer; J Alonso; Peter B Jones
The European Schizophrenia Outpatient Health Outcomes Study: baseline findings across country and treatment.
Acta psychiatrica Scandinavica. Supplementum 2003;(416):7-15.
2002: Lizheng Shi; Madhav A Namjoshi; Fan Zhang; Gian Gandhi; Eric T Edgell; Mauricio Tohen; Alan Breier; Josep Maria Haro
Olanzapine versus haloperidol in the treatment of acute mania: clinical outcomes, health-related quality of life and work status.
International clinical psychopharmacology 2002;17(5):227-37.
2001: I García-Cabeza; Juan-Carlos Gómez; José Antonio Sacristán; Eric T Edgell; M González de Chavez
Subjective response to antipsychotic treatment and compliance in schizophrenia. A naturalistic study comparing olanzapine, risperidone and haloperidol (EFESO Study).
BMC psychiatry 2001;1():7.
2000: Eric T Edgell; S W Andersen; B M Johnstone; B Dulisse; D Revicki; Alan Breier
Olanzapine versus risperidone. A prospective comparison of clinical and economic outcomes in schizophrenia.
PharmacoEconomics 2000;18(6):567-79.
2000: Susan H Hamilton; Eric T Edgell; Dennis A Revicki; Alan Breier
Functional outcomes in schizophrenia: a comparison of olanzapine and haloperidol in a European sample.
International clinical psychopharmacology 2000;15(5):245-55.
2000: Eric T Edgell; TR Hylan; Jolaine Reierson Draugalis; Stephen Joel Coons
Initial treatment choice in depression: impact on medical expenditures.
PharmacoEconomics 2000;17(4):371-82.
1999: Susan H Hamilton; Dennis A Revicki; Eric T Edgell; LA Genduso; Gary D Tollefson
Clinical and economic outcomes of olanzapine compared with haloperidol for schizophrenia. Results from a randomised clinical trial.
PharmacoEconomics 1999;15(5):469-80.
1999: Eric T Edgell; KJ Gregor; I Cockburn
Drug utilization patterns and outcomes associated with in-hospital treatment with risperidone or olanzapine.
Clinical therapeutics 1999;21(5):917-30.
1999: Eric T Edgell; K H Summers; TR Hylan; J Ober; Lyle J Bootman
A framework for drug utilization evaluation in depression: insights from outcomes research.
Medical care 1999;37(4 Suppl Lilly):AS67-76.
1997: Eric T Edgell; TR Hylan; José Antonio Sacristán
Sertraline. A pharmacoeconomic evaluation of its use in depression.
PharmacoEconomics 1997;11(4):377-80.